Dolutegravir Lamivudine Tablets
Introduction
Access to quality-assured antiretroviral medicines is an important part of HIV treatment programmes and pharmaceutical supply planning. For pharmaceutical importers, government procurement agencies, healthcare distributors, hospitals, and institutional buyers, selecting a reliable supplier requires careful attention to product quality, manufacturer credentials, regulatory documentation, and international shipping arrangements.
India has an established pharmaceutical manufacturing and export industry, supplying a wide range of finished medicines to international markets. For eligible buyers, sourcing from India may provide additional procurement options, subject to the product's availability, applicable authorisations, and destination-country regulations.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, offers pharmaceutical products across multiple therapeutic categories. Buyers interested in dolutegravir and lamivudine tablets can contact the company to enquire about potential sourcing options, subject to confirmation of the exact product, manufacturer, availability, documentation, and export eligibility.
This article explains the key considerations involved in sourcing dolutegravir lamivudine tablets from India, including product specifications, quality verification, documentation, storage, regulatory compliance, and international supply coordination.
Key Highlights
- Product: Dolutegravir and lamivudine tablets.
- Common fixed-dose strength: Dolutegravir 50 mg and lamivudine 300 mg per tablet.
- Therapeutic category: Antiretroviral medicine.
- Primary use: Treatment of HIV-1 infection in eligible patients under appropriate medical supervision.
- Dosage form: Oral film-coated tablet for the commonly referenced 50 mg/300 mg presentation.
- Potential buyers: Authorised pharmaceutical importers, distributors, institutional procurement agencies, and eligible healthcare organisations.
- Important procurement checks: Product identity, manufacturer, quality documentation, registration status, packaging, shelf life, and import permissions.
- Supplier enquiry: Contact Dolphin Pharmaceuticals to confirm whether the required product can be sourced for the intended market.
Product specifications, indications, packaging, and storage instructions must be verified against the exact manufacturer's approved product information.
Understanding Dolutegravir and Lamivudine Tablets
Dolutegravir and lamivudine are antiretroviral medicines used in the treatment of human immunodeficiency virus type 1 (HIV-1).
Dolutegravir belongs to the integrase strand transfer inhibitor class, while lamivudine is a nucleoside analogue reverse transcriptase inhibitor. The two medicines act on different stages of the HIV replication process.
When formulated together as a fixed-dose combination, they provide two active ingredients in a single tablet. The commonly referenced combination contains 50 mg of dolutegravir and 300 mg of lamivudine.
This combination is used as a complete HIV-1 treatment regimen in selected patients when the applicable prescribing criteria are met. Its suitability depends on the patient's treatment history, resistance profile, other medicines, and clinical circumstances. It is not appropriate for every person with HIV.
For pharmaceutical buyers, understanding the exact combination is essential because products containing dolutegravir and lamivudine may differ in strength, formulation, packaging, manufacturer, and regulatory status.
Procurement teams should therefore identify the requested product precisely rather than relying only on the active ingredients' names.
Dolutegravir Lamivudine Tablets: Product Details
The following information provides a starting point for pharmaceutical procurement enquiries.
- Generic name: Dolutegravir and lamivudine.
- Common fixed-dose strength: Dolutegravir 50 mg + lamivudine 300 mg per tablet.
- Dosage form: Oral film-coated tablet for the standard presentation described.
- Therapeutic category: Antiretroviral medicine.
- Therapeutic use: HIV-1 treatment in eligible patients, as specified in the approved product information.
- Route of administration: Oral.
- Packaging: Confirm the manufacturer's available pack sizes and packaging configuration.
- Manufacturer: Verify the actual manufacturer and manufacturing site for the specific product offered.
- Storage: Follow the exact product label. Some approved presentations specify storage below 30°C.
- Shelf life: Confirm the expiry date and remaining shelf life of the proposed batch.
- Availability: Must be confirmed directly with the supplier.
- Export eligibility: Depends on the product, destination market, and applicable regulatory authorisations.
These details should be treated as a product-identification guide rather than a guarantee that a particular brand or presentation is available from Dolphin Pharmaceuticals.
Why Pharmaceutical Buyers Consider Suppliers from India
International buyers may evaluate Indian pharmaceutical suppliers when developing sourcing strategies for essential medicines. However, supplier selection should be based on verifiable product and business information rather than country of origin alone.
1. Access to Pharmaceutical Sourcing Options
India's pharmaceutical sector includes manufacturers and suppliers across numerous therapeutic categories. Depending on their portfolios and commercial arrangements, suppliers may offer finished medicines or help buyers investigate product-specific sourcing possibilities.
When requesting dolutegravir lamivudine tablets, buyers should provide the required strength, brand preference, quantity, packaging, destination country, and any manufacturer or regulatory requirements.
Clear specifications help suppliers evaluate the enquiry accurately.
2. Manufacturer Transparency
The exporter and the manufacturer are not necessarily the same company. A supplier may export a medicine manufactured by another pharmaceutical company.
Buyers should confirm the manufacturer's legal name, manufacturing site, product identity, and relevant authorisations. This information should match the product label and supporting documentation.
3. Documentation for International Procurement
Cross-border pharmaceutical transactions require coordination between the supplier, exporter, importer, logistics provider, and relevant authorities.
Depending on the product and destination market, buyers may need product specifications, batch documentation, manufacturing details, quality certificates, and regulatory approvals.
Documentation should be reviewed before shipment rather than requested only after the goods have been dispatched.
4. Commercial and Supply Coordination
A clear commercial quotation helps buyers evaluate the proposed transaction. Important details include the unit price, quantity, minimum order requirements, payment terms, quotation validity, estimated lead time, packaging, and shipping conditions.
Buyers should also confirm whether the product is currently available or would need to be sourced separately.
Dolphin Pharmaceuticals: Pharmaceutical Sourcing Enquiries
Dolphin Pharmaceuticals is based in Surat, Gujarat, India, and offers pharmaceutical products across multiple therapeutic categories.
For buyers seeking dolutegravir and lamivudine tablets, the appropriate next step is to submit a product-specific enquiry and request confirmation of the relevant supply details.
Before proceeding, buyers should verify:
- Whether the exact dolutegravir/lamivudine combination can be sourced.
- The available brand and strength.
- The actual manufacturer and manufacturing site.
- The proposed pack size and quantity.
- Current availability and quotation.
- Applicable product and batch documentation.
- Storage and transportation requirements.
- Eligibility for export to the intended destination.
- Any destination-specific registration or import requirements.
A catalogue listing or supplier enquiry does not by itself establish that a particular medicine is in stock, approved for a destination market, or available for immediate export.
Dolphin Pharmaceuticals should be asked to confirm these points before a commercial order is finalised.
Quality Considerations When Sourcing Dolutegravir Lamivudine Tablets
Quality verification is a central part of pharmaceutical procurement. Buyers should establish a documented process for evaluating the supplier, manufacturer, product specifications, and proposed shipment.
Verify Product Identity
Confirm that the product contains the requested active ingredients in the correct strengths. Check the dosage form, pack size, brand name where applicable, and manufacturer details.
Do not assume that products with similar names or active ingredients are interchangeable without checking their approved product information.
Review Manufacturer Information
Confirm the legal identity of the manufacturer and, where relevant, the manufacturing site. Review applicable manufacturing licences and quality certifications, ensuring that they are valid and relevant to the specific product and facility.
A supplier's general quality claims should not replace verification of the actual manufacturer and product.
Request Appropriate Quality Documents
Depending on the product and transaction, buyers may request:
- Product specifications.
- Manufacturer details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product registration or approval documents, where required.
- Other supporting records requested by the importing authority.
Check that the documents correspond to the product and batch being offered. Resolve discrepancies before approving the shipment.
Check Packaging and Traceability
Review the packaging configuration, labelling, batch identification, expiry information, and tamper-evident features where applicable.
Maintain records that allow the supplied product to be traced to its manufacturer and batch. This supports inventory management, product verification, and applicable recall procedures.
Documentation Required for Pharmaceutical Export
The documents required for exporting dolutegravir lamivudine tablets depend on the product, transaction, and destination country's regulations.
Commercial Documents
Common commercial records may include:
- Proforma invoice.
- Commercial invoice.
- Packing list.
- Purchase order and agreed sales terms.
- Applicable transport documents.
Product and Quality Documents
Depending on the requirements, buyers may need:
- Product specifications and approved product information.
- Manufacturer and manufacturing-site details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant quality or manufacturing certificates.
- Product registration or approval records.
Regulatory and Import Documents
The importer should establish whether the destination market requires product registration, an import permit, an importer licence, or other authorisations.
Additional supporting information may be needed for regulatory assessment and customs clearance.
Important: No single document checklist applies to every country or every pharmaceutical shipment. Exporters and importers should confirm the requirements for the exact product and destination before arranging dispatch.
Storage, Packaging, and International Shipping
Proper storage and transportation help preserve the quality of pharmaceutical products throughout the supply chain.
Storage Requirements
Storage conditions must follow the manufacturer's approved product information. Some presentations of dolutegravir and lamivudine tablets specify storage below 30°C, but buyers should not assume that every product has identical requirements.
The product label should determine the applicable temperature range, packaging precautions, and other handling instructions.
Packaging Verification
Buyers should confirm the available packaging configuration and ensure that the proposed presentation meets the requirements of the destination market.
Packaging and labelling should be checked against applicable regulatory requirements before the order is approved.
Shelf-Life Planning
Confirm the batch expiry date and the minimum remaining shelf life required by the importer.
International transit, customs clearance, and local distribution can affect how much usable shelf life remains when the medicine arrives. These factors should be considered when planning the shipment.
Shipping Coordination
Agree on the shipping method, estimated dispatch date, expected transit time, and documentation responsibilities before dispatch.
The exporter, importer, and logistics provider should coordinate to ensure that the shipment is handled in accordance with the product's documented requirements.
Regulatory Compliance for Global Supply
Pharmaceutical export is subject to applicable laws in the exporting country and the destination market. A product's availability in India does not automatically mean that it can be imported or sold in another country.
Before confirming an order, buyers should establish:
- Whether the product is registered or otherwise authorised in the destination market.
- Whether an import permit or additional approval is required.
- Whether the importer is authorised to receive and distribute the medicine.
- Which manufacturer and quality documents must be submitted.
- Whether local packaging and labelling requirements apply.
- Whether any restrictions or additional conditions affect the proposed transaction.
For public-health programmes and institutional procurement, buyers should also verify whether a specific quality-assurance standard, approved supplier list, or procurement framework applies.
The World Health Organization maintains a public prequalification database for eligible medicines. Buyers should check the exact product and formulation in that database where WHO prequalification is a procurement requirement. Approval or prequalification of one product should not be assumed to apply to another product from the same supplier.
How to Evaluate a Dolutegravir Lamivudine Tablets Exporter
Choosing a supplier should involve a structured assessment of the complete transaction.
Step 1: Define the Product Requirement
Specify the generic name, strength, dosage form, pack size, quantity, preferred manufacturer, and destination country.
Step 2: Verify the Supplier and Manufacturer
Confirm the supplier's business details and its role in the supply chain. Identify the actual manufacturer and verify the relevant product information.
Step 3: Review Documentation
Request the applicable product, batch, quality, and regulatory documents. Ensure that the records are consistent with the medicine being offered.
Step 4: Confirm Import Eligibility
Check registration, permits, importer authorisation, and any destination-specific procurement requirements before committing to shipment.
Step 5: Compare Commercial Terms
Compare quotations using the same product specifications. Consider the total procurement cost, payment terms, packaging, lead time, and delivery conditions.
Step 6: Confirm Shipment Details
Agree on the dispatch schedule, transport arrangements, storage requirements, required documents, and responsibilities of the parties involved.
Following these steps helps buyers assess suppliers more consistently and identify issues before an order proceeds.
Frequently Asked Questions
1. What are dolutegravir lamivudine tablets used for?
The fixed-dose combination is used for HIV-1 treatment in eligible patients according to the applicable approved product information and the treating healthcare professional's assessment.
2. What is the common strength of dolutegravir and lamivudine tablets?
A commonly referenced fixed-dose combination contains dolutegravir 50 mg and lamivudine 300 mg per tablet. Buyers should verify the exact strength and formulation requested.
3. Can dolutegravir lamivudine tablets be exported from India?
International supply may be possible when the product, exporter, importer, and transaction meet all applicable requirements. Availability and export eligibility must be confirmed for the specific product and destination.
4. Does Dolphin Pharmaceuticals currently stock this combination?
Current stock and sourcing availability should be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required strength, quantity, preferred manufacturer, and destination country.
5. Which documents should pharmaceutical buyers request?
Depending on the product and destination, buyers may need product specifications, manufacturer details, batch information, a Certificate of Analysis where applicable, quality certificates, and relevant registration or import documents.
6. How should these tablets be stored?
Follow the storage conditions stated in the approved product information for the exact product supplied. Some presentations specify storage below 30°C, but the label for the supplied product takes precedence.
7. Can the tablets be supplied to every international market?
Not automatically. Product registration, import permissions, importer authorisation, and other requirements vary by country. Buyers should confirm the rules that apply to their destination before placing an order.
Conclusion
Exporting dolutegravir lamivudine tablets from India requires careful coordination of product specifications, manufacturer verification, quality documentation, regulatory compliance, and international logistics.
For pharmaceutical importers, distributors, institutional procurement teams, and eligible healthcare organisations, a reliable sourcing process begins with an exact product requirement and a clear understanding of the destination market's rules.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss potential sourcing requirements for dolutegravir and lamivudine tablets. Buyers should request confirmation of the exact formulation, manufacturer, availability, quality documents, quotation, and export eligibility before finalising an order.
For a product-specific enquiry, provide the required strength, pack size, quantity, destination country, preferred manufacturer, and known regulatory requirements. This allows the supplier to assess the request and clarify the next steps.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. Dolutegravir and lamivudine are prescription antiretroviral medicines. Treatment decisions must be made by qualified healthcare professionals, and products should be supplied through authorised pharmaceutical channels.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/